CUCCHIARA, VITO
 Distribuzione geografica
Continente #
EU - Europa 166
NA - Nord America 166
AS - Asia 58
SA - Sud America 2
Totale 392
Nazione #
US - Stati Uniti d'America 164
SE - Svezia 69
IT - Italia 51
CN - Cina 30
SG - Singapore 21
RU - Federazione Russa 17
DE - Germania 8
FI - Finlandia 8
IN - India 4
IE - Irlanda 3
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
GR - Grecia 1
HK - Hong Kong 1
JP - Giappone 1
MK - Macedonia 1
PL - Polonia 1
PY - Paraguay 1
SA - Arabia Saudita 1
UA - Ucraina 1
UY - Uruguay 1
Totale 392
Città #
New York 38
Milan 24
Ashburn 19
Boardman 16
Shanghai 16
Singapore 15
Lawrence 14
Princeton 14
Moscow 10
Helsinki 8
Rome 5
Macerata 4
Pune 4
Aci Sant'antonio 3
Dublin 3
Paderborn 3
Bethesda 2
Brussels 2
Limbiate 2
Los Angeles 2
Palermo 2
Québec 2
Vigonza 2
Zhengzhou 2
Asunción 1
Athens 1
Borås 1
Council Bluffs 1
Crotone 1
Freiburg im Breisgau 1
Gaithersburg 1
Giussano 1
Jeddah 1
London 1
Maldonado 1
Neyagawa 1
Nov Dojran 1
Padova 1
Romford 1
Seattle 1
Segrate 1
Sesto San Giovanni 1
Torrile 1
Totale 231
Nome #
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 34
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 25
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 23
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 23
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 23
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 22
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 21
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 21
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 21
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 20
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review 18
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 18
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 17
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 17
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
IL RUOLO DELLE CELLULE T DI MEMORIA RESIDENTI NEI TESSUTI NEL TUMORE PROSTATICO: IMPLICAZIONI PER GLI ESITI ONCOLOGICI 15
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer 15
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 13
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 11
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 6
Totale 422
Categoria #
all - tutte 4.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 9 2 7 0 3 3 3 0 0 0 3
2022/2023137 36 27 11 13 4 14 5 12 3 3 2 7
2023/2024216 3 18 23 16 17 49 3 19 0 16 17 35
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 422